Is the requirement for salvage medical therapy predictable in patients presenting with acute severe ulcerative colitis in a regional tertiary Australian setting?

被引：0
|
作者：
Sheehan, A. [1 ]
Swe, E. [1 ]
Day, M. [1 ]
Sullivan, B. [1 ]
Johnston, D. [1 ]
Mahy, G. [1 ]
机构：
[1] Townsville Univ Hosp, Townsville, Qld, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
349
引用
收藏
页码：187 / 188
页数：2
相关论文
共 50 条
  • [31] Have changing practices in salvage medical options affected colectomy rates in acute severe ulcerative colitis?
    Clark, Nicholas
    MacIsaac, Michael
    Little, Robert
    Vogrin, Sara
    Harrison, Maria
    Tiang, Thomas
    Keck, James
    Johnston, Michael
    Cunningham, Georgina
    Wright, Emily
    Connell, William
    INTERNAL MEDICINE JOURNAL, 2023, 53 (12) : 2231 - 2239
  • [32] Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort
    Uzzan, Mathieu
    Bresteau, Clement
    Laharie, David
    Stefanescu, Carmen
    Bellanger, Christophe
    Carbonnel, Franck
    Serrero, Melanie
    Viennot, Stephanie
    Nachury, Maria
    Amiot, Aurelien
    Altwegg, Romain
    Picon, Laurence
    Nahon, Stephane
    Vuitton, Lucine
    Soune, Philippe Ah
    Kirchgesner, Julien
    Peyrin-Biroulet, Laurent
    Bouhnik, Yoram
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (03) : 312 - 319
  • [33] Timing Is Everything: The Lifesaving Potential of Early Medical Therapy in Acute Severe Ulcerative Colitis
    Kathuria, Priya
    Higgins, Peter D. R.
    Berinstein, Jeffrey A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10): : 2139 - 2140
  • [34] UPADACITINIB AS SECOND- AND THIRD-LINE SALVAGE THERAPY FOR REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS
    Hassan, Syed Adeel
    Perry, Courtney
    Flomenhoft, Deborah
    Richardson, Brooks
    Kapur, Neeraj
    Berinstein, Jeffrey
    Barrett, Terrence
    INFLAMMATORY BOWEL DISEASES, 2024, 30
  • [35] UPADACITINIB AS SECOND- AND THIRD-LINE SALVAGE THERAPY FOR REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS
    Hassan, Syed Adeel
    Perry, Courtney
    Flomenhoft, Deborah
    Richardson, Brooks
    Kapur, Neeraj
    Berinstein, Jeffrey
    Barrett, Terrence
    GASTROENTEROLOGY, 2024, 166 (03) : S124 - S125
  • [36] Outcomes of patients admitted with acute, severe ulcerative colitis on biologic therapy: a retrospective analysis from a tertiary referral hospital
    Sabrie, Nasruddin
    Jogendran, Manisha
    Jogendran, Rohit
    Targownik, Laura E.
    JOURNAL OF THE CANADIAN ASSOCIATION OF GASTROENTEROLOGY, 2024, 7 (04) : 306 - 311
  • [37] OUTCOME OF ACUTE SEVERE ULCERATIVE COLITIS IN PATIENTS PREVIOUSLY EXPOSED TO IMMUNOSOPPRESSIVE THERAPY
    Deiana, S.
    Bagnoli, S.
    Faini, C.
    Gianni, E.
    Inghilesi, A. L.
    Manetti, N.
    Merola, V.
    Messeri, S.
    Annese, V.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E138 - E138
  • [38] Predictors of steroid therapy refractoriness in admitted Acute Severe Ulcerative Colitis patients
    Abdelmeguid, A.
    Elbanna, A.
    Ibrahim, F. A. E.
    Whitehead, E.
    Fitzgerald, A.
    Turnbull, J.
    Robertson, H.
    Elsheikh, W.
    Ellakany, A.
    Sebastian, S.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I560 - I560
  • [39] Outcome of acute severe ulcerative colitis in patients previously exposed to immunosuppressive therapy
    Deiana, Simona
    Bagnoli, Siro
    Manetti, Natalia
    Caini, Saverio
    Giannotta, Martina
    Scaringi, Stefano
    Annese, Vito
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (12) : 1432 - 1437
  • [40] Outcome of acute severe ulcerative colitis in patients previously exposed to immunosoppressive therapy
    Deiana, S.
    Bagnoli, S.
    Gabbani, T.
    Inghilesi, A. L.
    Manetti, N.
    Annese, V.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S349 - S349
12345